Results

Total Results: 1,426 records

Showing results for "stage".

261. Prostate-Cancer-Risk-Assessment-Genes Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_executive.pdf
     July 01, 2012 - and End Results Program, more men were diagnosed with prostate cancer at a younger age and earlier stage … in 2004–2005 than in the mid- to late 1990s, and disparity between ethnic groups in cancer stage at … management for localized prostate cancer is also debated, and only a small proportion of men with early stage … panels,47,55,59 and no increase in the AUC of a model based on age, PSA, Gleason score, and tumor stage … nonaggressive disease, and investigators should consider the possibility for subgroup analyses at the planning stage

262. Renal-Function Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-function_executive.pdf
     August 01, 2014 - Stages of chronic kidney disease Stage Description GFR, mL/min/ 1.73 m2 1 Kidney damage with normal … 1.2a Gender, age, ethnicity, stage of kidney disease (CKD stages I-IV or ESRD), dialysis status (for … 2.2a Gender, age, ethnicity, stage of kidney disease (CKD stages I-IV or ESRD), dialysis status (for … Use of cardiac biomarkers in end-stage renal disease. J Am Soc Nephrol. 2008 Sep;19(9):1643-52. … Plasma elimination of cardiac troponin I in end-stage renal disease.

263. Machine Learning Methods in Systematic Reviews: Identifying Quality Improvement Intervention Evaluations (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/machine-learning-quality_research.pdf
     September 01, 2012 - We tested a semiautomated literature screening process applied to the title and abstract screening stage … The decision at this stage of the review is whether to obtain full text or whether to discard. … At this review stage, reviewers are over-inclusive, and disagreements between different independent … At the title and abstract screening stage, reviewers have to process a large amount of information … Modeling reviewers‘ decisions at the title and abstract stage is distinctly different from modeling

264. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-adult-patients-with-bipolar-disorder-including-bipolar-i-and-bipolar-ii-disorder-what-is-the-comparative-effectiveness-of-available-treatments-including-psychotherapy-other-psychosocial-treatments-medications-and-other-so
     April 22, 2013 - (For example, an ethnic group, stage or severity of a disease.) … Available treatments have differential efficacy depending on polarity of episode (manic or depressive) and stage

265. Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/chronic-kidney-disease-anemia/research

266. 2020 EPC Program Year in Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/news/2020-year-in-review
     January 01, 2020 - End-stage Renal Disease in the Medicare Population: Frequency and Duration of Hemodialysis and Quality … Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease … Equivalent survival between lobectomy and segmentectomy for clinical stage IA lung cancer .

267. Disposition of Comments Report for Comparison of Characteristics of Nursing Homes and Other Residential Long-Term Care Settings for People With Dementia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dementia-nursing-home-characteristics_disposition-comments.pdf
     October 23, 2012 - and stage affects outcomes We modified the text here and in the introduction to note that prevalence … We also noted that the impact of dementia relates to the stage of the disease, which leads into the … Did stage affect outcomes? … While it was our original intent and desire to further explain applicability in the context of stage … Given the paucity of information regarding stage, we cannot make broad generalizations regarding how

268. Comparative Effectiveness of Treatment for Hepatitis C in Adults | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/hepatitis-c/research-protocol
     November 30, 2011 - according to patient subgroup characteristics, including but not limited to HCV genotype, age, race, sex, stage … according to patient subgroup characteristics, including but not limited to HCV genotype, age, race, sex, stage … harms differ according to patient subgroup characteristics, including HCV genotype, age, race, sex, stage … Subgroups included: HCV genotype (e.g., genotype 1 or 4 vs. 2 or 3); race (e.g., black vs. non-black); sex; stage

269. Hepatitis-C Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_executive.pdf
     November 01, 2012 - harms differ according to patient subgroup characteristics, including HCV genotype, age, race, sex, stage … performed in groups stratified by HCV genotype as well as by race, age, body weight, viral load, stage … trial of patients with genotype 2 or 3 infection (n=60) and advanced fibrosis or cirrhosis (Ishak stage … ribavirin reported harms in patients stratified by factors such as HCV genotype, age, race, sex, stage … Low bid = twice daily; CI = confidence interval; ESLD = end-stage liver disease; HCC = hepatocellular

270. Therapies for Clinically Localized Prostate Cancer: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-summary.pdf
     September 01, 2020 - Therapies for Clinically Localized Prostate Cancer: Evidence Summary Comparative Effectiveness Review Number 230 Therapies for Clinically Localized Prostate Cancer Evidence Summary Main Points • In men with clinically localized prostate cancer (CLPC) detected clinically rather than by prostate-speci…

271. Therapies for Clinically Localized Prostate Cancer: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
     September 01, 2020 - Therapies for Clinically Localized Prostate Cancer: Evidence Summary Comparative Effectiveness Review Number 230 Therapies for Clinically Localized Prostate Cancer Evidence Summary Main Points • In men with clinically localized prostate cancer (CLPC) detected clinically rather than by prostate-speci…

272. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-with-pku-there-is-now-a-pharmaceutical-drug-to-treat-this-condition-in-the-past-is-was-treated-by-medical-foods-that-eliminated-the-harmful-substance-phenylalanine-the-cost-of-the-new-drug-is-70k-year-the-cost-to
     June 17, 2009 - (For example, an ethnic group, stage or severity of a disease.) Those with the disease PKU.

273. What is the comparative renal of differnt contrast media used in radiographic imaging ? What is the comparative efficacy of different therapies in preventing contrast induced nephropathy? | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-renal-of-differnt-contrast-media-used-in-radiographic-imaging-what-is-the-comparative-efficacy-of-different-therapies-in-preventing-contrast-induced-nephropathy
     December 30, 2011 - (For example, an ethnic group, stage or severity of a disease.)

274. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/diagnosis-and-treatment-of-low-back-painbr-key-questionsbr-olliin-patients-with-low-back-pain-what-are-the-benefits-and-harms-of-identifying-risk-factors-for-chronicity-and-targeting-treatment-based-on-assessed-riskliliin-pat
     March 11, 2013 - (For example, an ethnic group, stage or severity of a disease.)

275. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/peripheral-artery-disease-pad-defined-as-peripheral-artery-disease-of-the-lower-extremities-1-does-aspirin-reduce-the-risk-of-adverse-cardiovascular-events-mi-stroke-cardiovascular-death-in-patients-with-pad-is-there-a-differ
     January 20, 2011 - (For example, an ethnic group, stage or severity of a disease.)

276. What are the best practice Behavioral Health programs for type 1 diabetes, type 2 diabetes and gestational diabetes. Does educational counseling help paitients improve control and adherence to treatment? | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-are-the-best-practice-behavioral-health-programs-for-type-1-diabetes-type-2-diabetes-and-gestational-diabetes-does-educational-counseling-help-paitients-improve-control-and-adherence-to-treatment
     May 04, 2012 - (For example, an ethnic group, stage or severity of a disease.) Yes.

277. Topic 0484 Treatments for Fecal Incontinence NSD FINAL SJ (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0572-140408.pdf
     January 09, 2014 - populations, interventions, comparators, and outcomes, will be further developed in the refinement stage

278. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/labor-nitrous-oxide_research-protocol.pdf
     August 24, 2011 - Leads will design the data collection forms and test them on multiple articles before initiating each stage … We will develop a simple categorization scheme for coding the reasons that articles, at the stage

279. Technical Brief Protocol_ 0369 Models of Survivorship Care_2-15-13_v14[1] (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-survivor-care-transition_research-protocol.pdf
     March 27, 2013 - survivorship o Payment considerations o Patient characteristics such as age, race/ethnicity, cancer type, stage … cancer survivorship care • Characteristics of patients enrolled (age, race/ethnicity, cancer type, stage … transitions of care), payment considerations, and patient characteristics such as age, race, cancer type, stage … eligibility, at recruitment, and at followup Population characteristics • Age, race/ethnicity, cancer type, stage

280. Stakeholder Assessment of Research and Data Needs for Comparative Effectiveness Research in Medicaid Populations | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/stakeholder-assessment-cer-needs-medicaid/abstract
     January 04, 2013 - Stakeholder Assessment of Research and Data Needs for Comparative Effectiveness Research in Medicaid Populations Abstract Archived January 4, 2013 Topic Abstract Background: Comparative effectiveness research and patient-centered outcomes research (CER/PCOR) can play a critical role in improving bot…